Cambridge, England-based TTP plc and New England Biolabs Inc., Ipswich, Mass.-based molecular biology enzyme company, entered a nonexclusive partnership to offer services to molecular diagnostic technology developers. The partnership will offer product development services in instrumentation, consumables and reagents, and help bring products to development.

Raritan, N.J.-based Ortho Clinical Diagnostics, an in vitro diagnostics company, entered into a strategic partnership with Brahms GmbH, of Hennigsdorf, Germany, part of Thermo Fisher Scientific Inc., to develop the Brahms procalcitonin assay to use with Ortho's Vitros systems. The assay is combined with clinical and lab findings during sepsis management.

No Comments